TREATMENT OF MYCOBACTERIUM-CHELONAE-INDUCED SKIN INFECTION WITH CLARITHROMYCIN

被引：44

作者：

FRANCK, N ^{[1
]}

CABIE, A ^{[1
]}

VILLETTE, B ^{[1
]}

AMOR, B ^{[1
]}

LESSANALEIBOWITCH, M ^{[1
]}

ESCANDE, JP ^{[1
]}

机构：

[1] HOP COCHIN, DEPT RHEUMATOL, F-75674 PARIS 14, FRANCE

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 1993年 / 28卷 / 06期

关键词：

D O I：

10.1016/S0190-9622(08)80660-3

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

[No abstract available]

引用

页码：1019 / 1021

页数：3

共 29 条

[1] AN INVITRO EVALUATION OF THE CELLULAR UPTAKE AND INTRAPHAGOCYTIC BIOACTIVITY OF CLARITHROMYCIN (A-56268, TE-031), A NEW MACROLIDE ANTIMICROBIAL AGENT [J].

ANDERSON, R ;

JOONE, G ;

VANRENSBURG, CEJ .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1988, 22 (06) :923-933

[2] INVITRO ACTIVITY OF CLOFAZIMINE AGAINST RAPIDLY GROWING NONCHROMOGENIC MYCOBACTERIA [J].

AUSINA, V ;

CONDOM, MJ ;

MIRELIS, B ;

LUQUIN, M ;

COLL, P ;

PRATS, G .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1986, 29 (05) :951-952

[3] COMPARATIVE INVITRO ACTIVITY OF THE NEW MACROLIDE A-56268 AGAINST MYCOBACTERIA [J].

BERLIN, OGW ;

YOUNG, LS ;

FLOYDREISING, SA ;

BRUCKNER, DA .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1987, 6 (04) :486-487

[4]

BORGHANS JG, 1973, AM REV RESPIR DIS, V107, P1

[5] ACTIVITIES OF 4 MACROLIDES, INCLUDING CLARITHROMYCIN, AGAINST MYCOBACTERIUM-FORTUITUM, MYCOBACTERIUM-CHELONAE, AND M-CHELONAE-LIKE ORGANISMS [J].

BROWN, BA ;

WALLACE, RJ ;

ONYI, GO ;

DEROSAS, V ;

WALLACE, RJ .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (01) :180-184

[6] DISSEMINATED DISEASE DUE TO MYCOBACTERIUM-CHELONEI TREATED WITH AMIKACIN AND CEFOXITIN - ABSENCE OF KILLING WITH EITHER AGENT AND POSSIBLE ROLE OF GRANULOCYTES IN CLINICAL-RESPONSE [J].

CARPENTER, JL ;

TROXELL, M ;

WALLACE, RJ .

ARCHIVES OF INTERNAL MEDICINE, 1984, 144 (10) :2063-2065

[7] INVITRO SUSCEPTIBILITY OF MYCOBACTERIUM-FORTUITUM AND MYCOBACTERIUM-CHELONEI TO SULFADIAZINE, SULFISOXAZOLE AND SULFATHIAZOLE [J].

CASAL, M ;

RODRIGUEZ, F .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1984, 3 (04) :320-321

[8]

DALOVISIO JR, 1981, REV INFECT DIS, V3, P1068

[9] ACTIVITY OF CLARITHROMYCIN AGAINST MYCOBACTERIUM-AVIUM INFECTION IN PATIENTS WITH ACQUIRED-IMMUNE-DEFICIENCY-SYNDROME - A CONTROLLED CLINICAL-TRIAL [J].

DAUTZENBERG, B ;

TRUFFOT, C ;

LEGRIS, S ;

MEYOHAS, MC ;

BERLIE, HC ;

MERCAT, A ;

CHEVRET, S ;

GROSSET, J .

AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (03) :564-569

[10] THE PHARMACOKINETICS OF CLARITHROMYCIN AND ITS 14-OH METABOLITE [J].

DAVEY, PG .

JOURNAL OF HOSPITAL INFECTION, 1991, 19 :29-37

← 1 2 3 →